Rinvoq (upadacitinib) is a prescription medicine that is a Janus kinase (JAK) inhibitor.
Rinvoq is used to treat adults with moderate to severe rheumatoid arthritis in patients that could not tolerate methotrexate or if treatment with methotrexate did not work well.
It is not known if Rinvoq is safe and effective in children under 18 years of age.
